We hypothesized that Kras mutations in epithelial cells disrupt the normal regulation of HO-1 in macrophages to resolve inflammation in pancreatitis, thereby prolonging HO-1 overexpression and therefore contributing to disease progression. Here, KRAS is linked to pancreatitis.